TUESDAY, May 7, 2024 (HealthDay News) — An experimental anti-nicotine drug appears to help people quit vaping, a new study says. Cytisinicline is a naturally occurring plant-based substance that binds to nicotine receptors in the brain, reducing a person’s cravings, researchers said. The drug has been shown effective in helpingContinue Reading

MONDAY, May 6, 2024 (HealthDay News) — A new combination therapy appears to boost the response rate for liver cancer patients receiving immunotherapy, according to results from a phase 2 clinical trial. The combo therapy involves bavituximab, a drug that neutralizes a fatty substance called phosphatidylserine that cancer cells useContinue Reading